{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,12]],"date-time":"2024-05-12T00:24:15Z","timestamp":1715473455995},"reference-count":12,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,5,11]]},"DOI":"10.7759\/cureus.60076","type":"journal-article","created":{"date-parts":[[2024,5,11]],"date-time":"2024-05-11T08:09:26Z","timestamp":1715414966000},"source":"Crossref","is-referenced-by-count":0,"title":["Joint Sparing: The Key to Unlocking Early Treatment Success in Eosinophilic Fasciitis"],"prefix":"10.7759","author":[{"given":"Tatsuki","family":"Yamada","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Etaro","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masatsune","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhito","family":"Hirose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.alit.2019.03.001","article-title":"Eosinophilic fasciitis: from pathophysiology to treatment","volume":"68","author":"Ihn H","year":"2019","unstructured":"Ihn H. Eosinophilic fasciitis: from pathophysiology to treatment. Allergol Int. 2019, 68:437-9. 10.1016\/j.alit.2019.03.001","journal-title":"Allergol Int"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1007\/s11926-017-0700-6","article-title":"Eosinophilic fasciitis: an updated review on diagnosis and treatment","volume":"19","author":"Mazori DR","year":"2017","unstructured":"Mazori DR, Femia AN, Vleugels RA. Eosinophilic fasciitis: an updated review on diagnosis and treatment. Curr Rheumatol Rep. 2017, 19:74. 10.1007\/s11926-017-0700-6","journal-title":"Curr Rheumatol Rep"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/0049-0172(88)90008-x","article-title":"Eosinophilic fasciitis: clinical spectrum and therapeutic response in 52 cases","volume":"17","author":"Lakhanpal S","year":"1988","unstructured":"Lakhanpal S, Ginsburg WW, Michet CJ, Doyle JA, Moore SB. Eosinophilic fasciitis: clinical spectrum and therapeutic response in 52 cases. Semin Arthritis Rheum. 1988, 17:221-31. 10.1016\/0049-0172(88)90008-x","journal-title":"Semin Arthritis Rheum"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.14160","article-title":"Diagnostic criteria, severity classification and guidelines of eosinophilic fasciitis","volume":"45","author":"Jinnin M","year":"2018","unstructured":"Jinnin M, Yamamoto T, Asano Y, et al.. Diagnostic criteria, severity classification and guidelines of eosinophilic fasciitis. J Dermatol. 2018, 45:881-90. 10.1111\/1346-8138.14160","journal-title":"J Dermatol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2014.01.019","article-title":"Diagnosis and classification of eosinophilic fasciitis","volume":"13","author":"Pinal-Fernandez I","year":"2014","unstructured":"Pinal-Fernandez I, Selva-O' Callaghan A, Grau JM. Diagnosis and classification of eosinophilic fasciitis. Autoimmun Rev. 2014, 13:379-82. 10.1016\/j.autrev.2014.01.019","journal-title":"Autoimmun Rev"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24031982","article-title":"Eosinophilic fasciitis: current and remaining challenges","volume":"24","author":"Mazilu D","year":"2023","unstructured":"Mazilu D, Bolta\u0219iu T\u0103taru LA, Mardale DA, et al.. Eosinophilic fasciitis: current and remaining challenges. Int J Mol Sci. 2023, 24:1982. 10.3390\/ijms24031982","journal-title":"Int J Mol Sci"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.37897\/RJR.2021.1.6","article-title":"Two case reports and a literature review on eosinophilic fasciitis","volume":"30","author":"Mazilu D","year":"2021","unstructured":"Mazilu D, Saulescu I, Ionescu R. Two case reports and a literature review on eosinophilic fasciitis. Rom J Rheumatol. 2021, 30:33-44. 10.37897\/RJR.2021.1.6","journal-title":"Rom J Rheumatol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2012.08.001","article-title":"Eosinophilic fasciitis (Shulman disease)","volume":"26","author":"Lebeaux D","year":"2012","unstructured":"Lebeaux D, S\u00e8ne D. Eosinophilic fasciitis (Shulman disease). Best Pract Res Clin Rheumatol. 2012, 26:449-58. 10.1016\/j.berh.2012.08.001","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4632.2007.03544.x","article-title":"Eosinophilic fasciitis: demographics, disease pattern and response to treatment: report of 12 cases and review of the literature","volume":"47","author":"Bischoff L","year":"2008","unstructured":"Bischoff L, Derk CT. Eosinophilic fasciitis: demographics, disease pattern and response to treatment: report of 12 cases and review of the literature. Int J Dermatol. 2008, 47:29-35. 10.1111\/j.1365-4632.2007.03544.x","journal-title":"Int J Dermatol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-014-2777-x","article-title":"The use of an elevated aldolase in diagnosing and managing eosinophilic fasciitis","volume":"34","author":"Nashel J","year":"2015","unstructured":"Nashel J, Steen V. The use of an elevated aldolase in diagnosing and managing eosinophilic fasciitis. Clin Rheumatol. 2015, 34:1481-4. 10.1007\/s10067-014-2777-x","journal-title":"Clin Rheumatol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2020.11.009","article-title":"Trunk involvement and peau d'orange aspect are poor prognostic factors in eosinophilic fasciitis (Shulman disease): a multicenter retrospective study of 119 patients","volume":"88","author":"Zuelgaray E","year":"2023","unstructured":"Zuelgaray E, Chevret S, Jachiet M, et al.. Trunk involvement and peau d'orange aspect are poor prognostic factors in eosinophilic fasciitis (Shulman disease): a multicenter retrospective study of 119 patients. J Am Acad Dermatol. 2023, 88:160-3. 10.1016\/j.jaad.2020.11.009","journal-title":"J Am Acad Dermatol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2015.3648","article-title":"Epidemiology and treatment of eosinophilic fasciitis: an analysis of 63 patients from 3 tertiary care centers","volume":"152","author":"Wright NA","year":"2016","unstructured":"Wright NA, Mazori DR, Patel M, Merola JF, Femia AN, Vleugels RA. Epidemiology and treatment of eosinophilic fasciitis: an analysis of 63 patients from 3 tertiary care centers. JAMA Dermatol. 2016, 152:97-9. 10.1001\/jamadermatol.2015.3648","journal-title":"JAMA Dermatol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/246388-joint-sparing-the-key-to-unlocking-early-treatment-success-in-eosinophilic-fasciitis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,11]],"date-time":"2024-05-11T08:09:29Z","timestamp":1715414969000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/246388-joint-sparing-the-key-to-unlocking-early-treatment-success-in-eosinophilic-fasciitis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,11]]},"references-count":12,"URL":"https:\/\/doi.org\/10.7759\/cureus.60076","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5,11]]}}}